Britannia Life Sciences Inc. (CSE:BLAB)
0.0650
+0.0050 (8.33%)
Oct 8, 2026, 9:04 AM EST
| Market Cap | 10.70M -30.6% |
| Revenue (ttm) | 406.44K +6.0% |
| Net Income | 16.54M +122.3% |
| EPS | 0.10 +122.3% |
| Shares Out | 164.59M |
| PE Ratio | 0.70 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100,000 |
| Open | 0.0650 |
| Previous Close | 0.0600 |
| Day's Range | 0.0650 - 0.0650 |
| 52-Week Range | 0.0600 - 0.1100 |
| Beta | 0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 27, 2026 |